04:32 PM EDT, 10/07/2025 (MT Newswires) -- Edward M. Kaye, Director, on October 03, 2025, sold 42,461 shares in Stoke Therapeutics ( STOK ) for $1,065,206. Following the Form 4 filing with the SEC, Kaye has control over a total of 49,124 common shares of the company, with 49,124 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1623526/000152278025000004/xslF345X05/form4-10072025_081055.xml